Biocorrx INC Form 4 insider transactions

BioCorRx Inc. President Louis C. Lucido has significantly increased his holdings of company stock through a series of issuances related to service agreements, director fees, and debt exchanges.

BioCorRx Inc.'s CEO and CFO, Lourdes Felix, has been granted a substantial number of company shares, reflecting her ongoing commitment and expanded role within the pharmaceutical company.

Louis C. Lucido, a director, 10% owner, and President of BioCorRx Inc., reports the acquisition of 44,220 shares of common stock on June 28, 2024, due to director and executive service agreements.

Director Luisa Ingargiola received shares of BioCorRx Inc. as compensation for her services, according to a recent SEC filing.

Lourdes Felix, CEO, CFO, and Director of BioCorRx Inc., acquired 10,204 shares of common stock on June 28, 2024, as part of her director compensation agreement.

Louis C. Lucido, a director, 10% owner, and President of BioCorRx Inc., acquired 22,831 shares of common stock on May 31, 2024, as part of his Executive Service Agreement.

Louis C. Lucido, a director, officer, and 10% owner of BioCorRx Inc., acquired 21,552 shares of common stock on April 30, 2024, as part of his Executive Service Agreement.

Joseph Galligan, a director of BioCorRx Inc., received shares of common stock as compensation for his services, according to a recent SEC filing.

Director Brady James Granier received fully vested stock options for 16,698 shares of BioCorRx Inc. on March 28, 2024.

Director Harsha Murthy reports acquiring shares of BioCorRx Inc. as part of a director agreement.

Louis C. Lucido, a director, 10% owner, and President of BioCorRx Inc., acquired shares of common stock on March 28, 2024, as part of his director and executive service agreements.

Lourdes Felix, a Director and CEO/CFO of BioCorRx Inc., acquired 5,566 shares of common stock as compensation for her services, according to a recent SEC Form 4 filing.

Louis C. Lucido, President of BioCorRx Inc., acquired additional shares of common stock in January and February 2024 as part of his Executive Service Agreement.